Comera Investor Presentation Deck

Content ● ● ● ● Need for and problems with Subcutaneous biologic administration Comera SQore TM platform technology Identifying and characterizing excipients Computational screening ● New stabilizing excipients Experimental validation. Case studies on formulation development of mAb A Formulation Buffer screening ● ● • Viscosity and stability optimization ● DOE for formulation optimization ● Conclusions Comera LIFE SCIENCES 2

View entire presentation